know more, do more

Advancing endocrinology and improving public health

Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field. 

the latest
Meetings & Events

Register for ENDO 2025

March 05, 2025

With over 7,000 attendees, nearly 2,500 abstracts and over 200 other sessions, ENDO is the leading global meeting on endocrinology research and clinical care. ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world.

Awards

Transatlantic Alliance Award Nominations Are Open

April 01, 2025

The Transatlantic Alliance Award honors a leading endocrinologist whose collaborative work has advanced research across Europe and the United States. Submit your nomination to recognize a global leader in basic or clinical endocrinology. Nominations for 2026 close July 30, 2025.

Store

Now Available: Pediatric ESAP™ 2025–2026

April 14, 2025

Navigate the complexities of endocrine care for children and adolescents with the Pediatric Endocrine Self-Assessment Program (ESAP)™ 2025–2026. Enhance patient care with 100 new case-based questions covering growth, diabetes, reproduction, and more. Available in print, eBook, and online, with interactive modes to build knowledge and confidence. Order now.

Training & Education

Obesity Fellows Program Application Period Now Open

April 17, 2025

Applications are now being accepted for the 2025 Obesity Fellows Program, September 19-20, a blended learning experience on best practices in obesity care, exclusively for endocrinology fellows. Travel, two-night hotel accommodation, and meal expenses will be covered for up to 50 US-domestic fellows. Applications are due Wednesday, May 7 at 11:59 PM ET.

Advocacy

Advocacy in Action

April 11, 2025

Learn about how the Society is advocating for you, your patients, and your research as well as the latest in anti-obesity medication coverage.

We Are Endocrinology

Deena Adimoolam
“I use media to share a message of prevention and recognition of many endocrine diseases, especially diabetes and obesity. As a member of the Endocrine Society, I have also had the opportunity to continue this work with Society members who share in my vision and passion. I work closely with the Endocrine Society’s Hormone Health Network to spread awareness on various endocrine diseases through patient education tools and media.” – Deena Adimoolam, MD
We are an 18,000 member strong global community
A champion for the Society’s guidelines, Chris has been passionate about improving our guideline development methodology as well as about making guideline content more accessible to readers around the world. – Christopher McCartney, MD

Advantages of Membership

Need more info?

Learn more about the advantages of membership

Endocrine Society News

Endocrine Society disappointed in failure to extend Medicare and Medicaid coverage to anti-obesity medications

April 07, 2025

The Endocrine Society is extremely disappointed the administration has chosen not to finalize a rule that would have made anti-obesity medications more accessible to millions of Americans with obesity.

Endocrine Society statement on HHS restructuring, mass firings, and scientific review

March 28, 2025

A major reorganization of the U.S. Department of Health and Human Services (HHS)—including massive cuts to the federal workforce—threatens scientific progress that drives our economy and improves the public’s health.

Endocrine Society calls for restoration of Diabetes Prevention Program

March 19, 2025

Three decades of landmark research into type 2 diabetes prevention abruptly ended this month due to government funding cuts.

View More

Featured Journal Articles

Multiple Endocrine Neoplasia Type 1 With Adrenal Cortical Adrenocortical Carcinoma

April 15, 2025

The authors present a 49-year-old woman who was hospitalized with symptoms of hypoglycemia. Twenty-five years earlier, she had been diagnosed with a pituitary macroprolactinoma.

The Unfolding Story of Protein Misfolding Causing Alzheimer Disease in Recipients of Human Pituitary Growth Hormone

April 15, 2025

In this perspective article, we trace some of the history of the connections between the early preparations of growth hormone extracted from human pituitaries to the detection of these two neurodegenerative diseases in treated patients.

Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala

April 15, 2025

We review the extant literature demonstrating central nucleus of the amygdala activation via glucagon-like peptide 1 receptor agonists across multiple species and through multiple routes of administration.

View More
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.